НовостиBenzingaGuggenheim Maintains Buy on Damora Therapeutics, Lowers Price Target to $59 Guggenheim Maintains Buy on Damora Therapeutics, Lowers Price Target to $59 Benzinga 2026.11.06 16:24 (GMT+0) Открыть на Benzinga Другие новости